Dishman Pharma sets up 3 API facilities for Rs 150 cr

New Delhi, May 7 (UNI) Dishman Pharmaceuticals and Chemicals today said it has installed three active pharmaceutical ingredient (API) units at its Bavla facility at a cost of about Rs 150 crore under project Taurus.

The fourth API facility will be dedicated for cytotoxic and cytotoxic compounds, such as anti-cancer drugs and hormones, a company statement said.

This facility will be ready for commissioning before the end of the current calendar year, the statement added.

UNI SR mp us1959